Clean Cells

Clean Cells acquires Stem Genomics to strengthen cell therapy quality control and expand US presence

Nantes, France, June 18, 2026 – Clean Cells, a leading biopharmaceutical quality control services provider specializing in biologics GMP testing, today announces the acquisition of Stem Genomics, a provider of next-generation quality controls for stem cell therapy, including the company’s core asset, its iCS-digital PSC technology platform. This strategic purchase complements Clean Cells’ offerings as a GMP specialist for…

Clean Cells acquires Karyologic to accelerate expansionin US biologics market

8 April 2025 — Montaigu-Vendée, near Nantes, France — Clean Cells, part of the Clean Biologics group, a leading biopharmaceutical quality control services provider specializing in biologics GMP testing, today announces the strategic acquisition of Karyologic Inc., a specialized karyotyping services company based in Durham, North Carolina, USA. This strategic acquisition marks a key milestone…
4 Rue Nicolas Sadi Carnot ZA le Point du Jour 85600 MONTAIGU – VENDÉE FRANC

+33 (0)2 51 09 27 57